| Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment J Park, Y Choi, H Chang, W Um, JH Ryu, IC Kwon Theranostics 9 (26), 8073, 2019 | 303 | 2019 |
| Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy MK Shim, J Park, HY Yoon, S Lee, W Um, JH Kim, SW Kang, JW Seo, ... Journal of Controlled Release 294, 376-389, 2019 | 140 | 2019 |
| Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy S Lim, J Park, MK Shim, W Um, HY Yoon, JH Ryu, DK Lim, K Kim Theranostics 9 (25), 7906, 2019 | 120 | 2019 |
| Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity S Yang, MK Shim, WJ Kim, J Choi, GH Nam, J Kim, J Kim, Y Moon, ... Biomaterials 272, 120791, 2021 | 113 | 2021 |
| Current limitations and recent progress in nanomedicine for clinically available photodynamic therapy J Park, YK Lee, IK Park, SR Hwang Biomedicines 9 (1), 85, 2021 | 87 | 2021 |
| Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex J Park, JU Choi, K Kim, Y Byun Biomaterials 147, 145-154, 2017 | 83 | 2017 |
| Dual-modal imaging-guided precise tracking of bioorthogonally labeled mesenchymal stem cells in mouse brain stroke S Lim, HY Yoon, HJ Jang, S Song, W Kim, J Park, KE Lee, S Jeon, S Lee, ... ACS nano 13 (10), 10991-11007, 2019 | 70 | 2019 |
| NLRP3 ubiquitination—a new approach to target NLRP3 inflammasome activation M Akther, ME Haque, J Park, TB Kang, KH Lee International Journal of Molecular Sciences 22 (16), 8780, 2021 | 67 | 2021 |
| Caspase-3/-7-specific metabolic precursor for bioorthogonal tracking of tumor apoptosis MK Shim, HY Yoon, S Lee, MK Jo, J Park, JH Kim, SY Jeong, IC Kwon, ... Scientific reports 7 (1), 1-15, 2017 | 67 | 2017 |
| Functional transformations of bile acid transporters induced by high-affinity macromolecules TA Al-Hilal, SW Chung, F Alam, J Park, KE Lee, H Jeon, K Kim, IC Kwon, ... Scientific reports 4 (1), 4163, 2014 | 61 | 2014 |
| Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy W Um, J Park, H Ko, S Lim, HY Yoon, MK Shim, S Lee, YJ Ko, MJ Kim, ... Biomaterials 224, 119494, 2019 | 59 | 2019 |
| Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo S Lee, S Jung, H Koo, JH Na, HY Yoon, MK Shim, J Park, JH Kim, S Lee, ... Biomaterials 148, 1-15, 2017 | 58 | 2017 |
| Oligomeric bile acid-mediated oral delivery of low molecular weight heparin TA Al-Hilal, J Park, F Alam, SW Chung, JW Park, K Kim, IC Kwon, IS Kim, ... Journal of Controlled Release 175, 17-24, 2014 | 57 | 2014 |
| The molecular mechanism of polyphenols with anti-aging activity in aged human dermal fibroblasts JH Lee, J Park, DW Shin Molecules 27 (14), 4351, 2022 | 55 | 2022 |
| Regulation of caspase-8 activity at the crossroads of pro-inflammation and anti-inflammation JH Han, J Park, TB Kang, KH Lee International Journal of Molecular Sciences 22 (7), 3318, 2021 | 54 | 2021 |
| Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex J Kim, G Shim, H Choi, J Park, SW Chung, S Kim, K Kim, IC Kwon, ... Biomaterials 33 (17), 4424-4430, 2012 | 47 | 2012 |
| Statins decrease programmed death-ligand 1 (PD-L1) by inhibiting AKT and β-catenin signaling WJ Lim, M Lee, Y Oh, XQ Fang, S Lee, CH Lim, J Park, JH Lim Cells 10 (9), 2488, 2021 | 31 | 2021 |
| A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway JU Choi, SW Chung, TA Al-Hilal, F Alam, J Park, F Mahmud, JH Jeong, ... Biomaterials 139, 56-66, 2017 | 31 | 2017 |
| Heparin and its derivatives: challenges and advances in therapeutic biomolecules N Banik, SB Yang, TB Kang, JH Lim, J Park International journal of molecular sciences 22 (19), 10524, 2021 | 30 | 2021 |
| Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy MK Shim, J Na, IK Cho, EH Jang, J Park, S Lee, JH Kim Journal of Controlled Release 331, 434-442, 2021 | 30 | 2021 |
